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Abstract In this study, we compared the immunoglobulin
E immunological reactions of 23 soy-allergic, nine soy-
sensitive, and four non-allergic human sera to soybean
proteins separated by 1D and 2D gel electrophoresis and
screened by Western blot. This method led to novel allergen
identification in soybean proteins by tandem mass spec-
trometry analysis of reactive proteins. Soybean is one of the
eight most significant foods which provoke allergic
reactions among North Americans. Previous studies have
identified several putative allergens present in soybean
seeds; however, many of these reports did not employ mass
spectrometry to conclusively identify the allergenic pro-
teins. Reviews have suggested that soybean seeds may
contain between 10 and 20 different proteins responsible
for provoking allergic reactions among sensitive patients.
We report, in this study of North American patients, a total
of 19 potentially allergenic proteins including ten identified
by mass spectrometry and five novel allergens. We have
also made extensive use of soybean lines lacking various
subunits of the major seed storage proteins, glycinin and β-
conglycinin. By using these knockout lines in Western blots
with patient serum, it was conclusively demonstrated that
some patients react predominantly to only a few proteins,
while most react to four to six proteins. The findings herein
describe the main allergic proteins present in soybean
seeds, the relative significance of these allergens among
North Americans, and some genetic lines of soybean
lacking individual allergens.
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Introduction
Soybeans (Glycine max L. Merr.) are an excellent source of
high-quality protein, polyunsaturated fats, vitamins, miner-
als, and other nutrients for both human food and animal feed
(Krishnan 2000; Wang et al. 2003). Soy proteins are added to
a wide range of food products, such as infant formulas, meal
replacement drinks, and sports bars and beverages. As well as
increasing the nutritional value of the food, the US Food and
Drug Administration and the Joint Health Claims Initiative in
the UK, among other regulatory bodies, have established that
adding soy proteins to food reduces cholesterol levels, thereby
lowering the risk of cardiovascular disease.
Food allergies are an increasing health and wellness
concern in most countries of the world, with North America
being no exception. Currently, it is estimated that 2–6% of
the North American population suffers from food allergies,
and soybean is one of the eight foods that requires labeling
in many countries (EU, Japan, Canada, and USA). Due to
its widespread use in the food and beverage industry,
soybean is often a “hidden ingredient,” which adds to its
significance as a food allergen (Zarkadas et al. 1999; Hefle
2001; L’Hocine and Boye 2007).
Soybean seed contains approximately 36–38% protein
composed of two major storage proteins, glycinin, and β-
conglycinin, which account for ~40% and ~25% of the total
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protein, respectively (Fehr et al. 2003; Nielsen et al. 1989).
Because glycinin and β-conglycinin greatly impact on the
nutritional value and quality of soybean products, these two
storage proteins and the genes encoding them have been
studied extensively.
Immunoglobulin E (IgE) Western blotting analysis has
been widely used for the identification of food allergens
(Batista et al. 2007; Xiang et al. 2008; Herian et al. 1990).
However, Western blotting alone is often insufficient to
accurately identify allergens due to multiple proteins
occupying a single band or gel spot. In this study, we show
how the use of high-resolution 2D gel electrophoresis
combined with knockout soy lines and tandem mass
spectrometry (MS) allows for allergen identification with
much higher confidence levels. Liquid chromatography
(LC)/MS/MS has evolved into a highly powerful tool for
accurate mass measurement and produces molecular weight
(Mw) information as well as sequence specific fragmenta-
tion data for each peptide. These data are then used to
search a protein database for the identification of proteins
(Perkins et al. 1999). Recently generated soybean proteome
databases using high-resolution 2D gel separation coupled
with rapidly expanding genome sequence data makes for an
attractive method to conclusively identify IgE reactive
proteins (Hajduch et al. 2005).
The three main objectives of this study were to use high-
resolution gel electrophoresis andWestern blotting to separate
and locate the soybean proteins capable of binding IgE from
soybean-allergic and sensitive patient serum, to use MS to
confirm previously reported allergens and identify potential
novel allergens, and to rank and attempt to draw conclusions
on the prevalence and significance of these allergens among
North Americans with soybean food allergies.
Materials and Methods
Materials
Immobilized pH gradient (IPG) Ready Strips™, pH 4–7
and 5–8, 7 and 17 cm, Precision Plus Protein™ Standards,
BioSafe™ Coomassie, and Immun-Blot™ PVDF mem-
brane (0.2µm) were obtained from Bio-Rad Laboratories,
Mississauga, ON. Immobiline DryStrips, pH6–11, 7 and
17 cm, carrier ampholytes 3.5–10, IPG buffer 6–11, and ECL
Plus horseradish peroxidase (HRP) substrate were from GE
Healthcare, Baie d'Urfé, QC. Low-melting agarose SeaPla-
que™ was obtained from BioWhittaker Molecular Applica-
tions, Rockland, ME. Acrylamide/bisacrylamide solution,
urea, thiourea, glycine, glycerol, sodium dodecyl sulfate
(SDS), 3-[(3-cholamidopropyl) dimethylammonio]-1-pro-
panesulfonate (CHAPS), and Tris (base) were obtained from
BioShop Canada Inc., Burlington, ON. N,N,N′N′-tetramethy-
lenediamine, 1,4-dithiothreitol (DTT), Brilliant (Coomassie)
Blue R-250, iodoacetamide, trichloroacetic acid, and β-
mercaptoethanol were obtained from Sigma-Aldrich Canada,
Ltd., Oakville, ON. Blocking reagent was purchased from
Roche Diagnostics, Laval, Qc. Anti-human IgE HRP was
purchased from Southern Biotech, Birmingham, AL. All
other chemicals and reagents were of the highest purity
commercially available.
Selection of Plant Materials
The soybean lines used in this investigation consisted
mostly of Harovinton but also included null genotypes,
with different glycinin and β-conglycinin subunit compo-
sitions developed by Dr. V. Poysa at the Greenhouse and
Processing Crops Research Centre, Harrow, ON (Poysa et
al. 2006; Zarkadas et al. 2007). Harovinton is a northern-
adapted cultivar used as the quality standard for Canadian
tofu-type soybeans.
Soy-Allergic and Soy-Sensitive Human Sera
A total of 32 human sera were acquired from two sources:
nine Canadian from Drs. Susan Hefle and Steve Taylor
(University of Nebraska) and 23 American from PlasmaLab
International, Everett, WA (www.plasmalab.com). Clinical
symptoms of allergy to soybean and ImmunoCAP scores
for four legume allergens are listed in Table 1. All of the
Canadian patients were allergic to soy; however, only 14 of
the American patients were allergic to soy, and nine were
sensitive as represented by their ImmunoCAP score.
Patients with clinical symptoms of allergy were designated
allergic; while those lacking symptoms but with high
ImmunoCAP scores were designated sensitive.
Soybean Protein Preparation for 1D Polyacrylamide Gel
Electrophoresis
Soybean seeds were ground into a fine powder by using a
standard coffee grinder or a mixer mill MM301 (Retsch,
Newtown, PA www.retsch-us.com/us/). The ground seed
(50 mg) was extracted directly into 1 mL Tris-buffered
saline with EDTA (20 mM Tris, pH7.6; 150 mM NaCl, and
1 mM EDTA) for 2–3 h at RT on a nutator shaker. The
slurry was centrifuged at 18,000×g for 10 min, and the
supernatant was kept at −20°C until used. Total protein
content was estimated by Bradford microassay (Bradford
1976) and typically ranged from 10–15 mg/mL.
Soybean Protein Preparation for 2D Gel Electrophoresis
Ground soybean (50 mg) was either resuspended directly in
1 mL of rehydration buffer [8 M deionized urea, 2 M
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deionized thiourea, 2% (w/v) CHAPS, 50 mM DTT, 0.2%
(v/v) carrier ampholytes, and trace of bromophenol blue],
then centrifuged at 18,000×g for 10 min, after which the
supernatant was kept at −20°C until used or the ground
soybean was extracted as previously described (Zarkadas
et al. 2007) with the following modifications. All
centrifugations were performed at 35,000×g, and the
pellet was dried on ice in a fume hood for 20 min. Total
protein content was estimated by a modified Bradford
microassay, in which rehydration buffer was added to the
standard curve samples and HCl (2.6 mM) was added to
all samples.
Table 1 Clinical characteristics of the 32 soy allergic/sensitive patients
Patient Nationality Gender Age Allergic symptoms to soy ImmunoCAP scores (kU/L)
Soy Peanut Green pea White bean
CS2 A M 33 OAS, con, rh, oe, u, em >100 – – 3.01
LMa C F 23 loe, bs, u, pr, gi 68×c – – –
MHa A M 20 wh, u, dys, thi 55.0 43.2 29.7 36.9
DB C M 42 ana, bp, 34.8 – – –
RB A F 37 OAS, ec, con, u, as, gi 34.0 – – –
SC A M 38 ec, con, rh, u 33.27d – – –
SN A M 35 OAS, ec, con, rh, u, gi, oe, em 33.0 – – –
DGa A M 18 – 15.0 >100d (ana) – –
RMb A M 40 10–14 30.9 11.9 21.7
RDb A M 35 10–12 15.4 – –
LN A F 43 con, rh, wh, pr, thi 11.3 – – –
CCa C F 35 u, oe, dys, dia 11×c – – –
LA A F 27 ana, u, em, gi, dia 9.54 15.6 12.5 16.2
LSb A F 45 8–13 17.4 9.03 15.7
RJb A M 33 7.17 14.8 <0.35 12.5
DDa A M 24 ec, gi 6.0 16.1 – –
CYb A F 32 5.68 12.3 4.01 13.8
COb A M 23 5.45 5.92 4.75 6
PKb A M 42 5.15 2.04 – –
JC A M 46 ec, con,rh 5.06 5.28 3.75 4.28
CS C F 25 dys, wh, thi 5×c – – –
CM A F 29 con, rh, pr 5.0 7.86 – –
KPa A F 26 con, rh, u, wh, as, dys 4.94 100 (ana) 9.43 0.78
MDb A F 64 4.42 5.14 – –
AJa A F 18 OAS, con, rh, pr, ang 4–5 5.86 3.03 4.61
REa A M 51 OAS, ec, u, pr, as, nau 4.31 58 (ana) 2.52 3.77
TOb A F 41 4 4 – –
AG C F 32 dys, rh 3.18 – – –
RC C M 54 u, oe, thi 3×c – – –
HS C F 31 ec 0.6 – – –
DPa C F 25 ana, con, u, em, thi – – – –
08a C M 28 ana, wh, pr, thi – – – –
A American, C Canadian, OAS oral allergy syndrome, con conjunctivitis, rh rhinitis, oe oedema, u urticaria, em emesis, loe laryngeal oedema, bs
bronchospasm, pr pruritus, gi gastrointestinal pain, wh wheezing, dys dyspnea, thi tightness of throat or chest, ana anaphylaxis, bp blood pressure
increase, ec eczema, as asthma, dia diarrhea, ang angioedema, nau nausea, (–) not determined
a Also allergic to peanuts
b Soy-sensitive
c RAST score
d DPC immulite score
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1D Gel Electrophoresis
Soybean protein samples for gel application were prepared
as previously described (Zarkadas et al. 2007) with the
following modifications: After heating at 98°C, the samples
were centrifuged 10 s at ~1,000 g prior to application.
Electrophoresis was performed on vertical slab gels (Mini-
Protean II or Protein II xi, Bio-Rad) containing 12.5% or
15% acrylamide with a 4% stacking gel according to
Laemmli (1970) at constant voltage 100–150 V (~1.5 h) for
the Mini-Protean II and at 50–100 V for the Protean II xi
(~20 h) until the tracking dye migrated to the bottom of the
gel. Gels were either Coomassie-stained or transferred to
polyvinylidene fluoride (PVDF) membrane for Western
blotting. Coomassie-stained gels were scanned and dried as
previously described (Zarkadas et al. 2007).
Isoelectric Focusing using Immobiline pH Gradient Strips
Isoelectric focusing was performed on 7 or 17 cm, pH4–7 or
5–8, IPG ReadyStrips linear strips or on 7 or 17 cm, pH 6–11,
Immobiline DryStrips as previously described (Zarkadas et al.
2007). Strips were hydrated with 75–100µg protein (7 cm)
in 125μl of rehydration buffer or with 0.5–1.0 mg protein
(17 cm) in 300µl of rehydration buffer according to the
manufacturer’s instructions. The 7-cm strips were focused at
20°C at 250 V for 20 min, 4,000 V for 2.5 h followed by
4,000 V for 10,000 Vh for a total of ~14,000 Vh, whereas the
17-cm strips were focused at 20°C at 250 V for 20 min,
10,000 V for 2.5 h followed by 10,000 V for 40,000 Vh for a
total of ~50,000 Vh.
2D Gel Electrophoresis
2D electrophoresis was performed as previously described
for the 7-cm strips (Zarkadas et al. 2007). For the 17-cm
strips, 4 ml of equilibration buffers I and II were used, and
the strips were embedded on top of 12.5% or 15%
acrylamide gels for the Protean II XL (20 cm, Bio-Rad).
Gels were Coomassie-stained and scanned as previously
described or stained with Bio-Safe Coomassie as per the
manufacturer’s instructions for MS.
IgE Western Blotting
Proteins separated on 1D or 2D gels were transferred to
PVDF membranes at 100 V for 1 h in Towbin buffer
supplemented with 20% methanol in a Mini-Trans-Blot
Cell (Bio-Rad), dried 1 h at RT, then blocked O/N at 4°C in
1% blocking reagent in Tris-buffered saline Tween-20
(TBST; 20 mM Tris, pH7.6, 150 mM NaCl, 0.05%
Tween-20) in glass dishes. 1D membranes were cut into
strips and hybridized in 10-ml polypropylene tubes with
1/25–1/1,400 of patient serum in TBST supplemented with
0.5% blocking reagent O/N at 4°C on a nutator with gentle
rotation, whereas 2D membranes were hybridized directly
in the glass dishes. Membranes were vigorously washed in
TBST 5×10 min. Secondary antibody, anti-human IgE
HRP was added at 1/2,000–1/2,500 in TBST supplemented
with 0.5% blocking reagent for 1 h at RT, then washed as
before. Blots were detected with ECL Plus substrate and
scanned with a Molecular Dynamics Storm Imager 840 (GE
Healthcare). PVDF membranes were Commassie-stained
post-detection and scanned as described previously.
Mass Spectrometry (LTQ)
Linear trap quadrupole (LTQ) MS was performed at the
Proteomics Platform of the Eastern Quebec Genomics
Centre as follows.
Protein In-Gel Digestion
Bands of interest were placed in 96-well plates and then
washed with water. Tryptic digestion was performed on a
MassPrep liquid handling robot (Waters, Milford, USA)
according to the manufacturer’s specifications and to the
protocol of Shevchenko et al. (1996), with modifications
suggested by Havlis et al. (2003). Briefly, proteins were
reduced with 10 mM DTT and alkylated with 55 mM
iodoacetamide. Trypsin digestion was performed using
105 mM of modified porcine trypsin (Sequencing grade,
Promega, Madison, WI) at 58°C for 1 h. Digestion products
were extracted using 1% formic acid, 2% acetonitrile
followed by 1% formic acid and 50% acetonitrile. The
recovered extracts were pooled, vacuum centrifuge dried,
and then resuspended into 8µl of 0.1% formic acid, and 4µl
were analyzed by MS.
Mass Spectrometry
Peptide samples were separated by online reversed-phase
(RP) nanoscale capillary LC (nanoLC) and analyzed by
electrospray MS. The experiments were performed with a
Thermo Surveyor MS pump connected to a LTQ linear ion
trap mass spectrometer (ThermoFisher, San Jose, CA,
USA) equipped with a nanoelectrospray ion source (Ther-
moFisher, San Jose, CA, USA). Peptide separation took
place on a PicoFrit column BioBasic C18, 10 cm×
0.075 mm internal diameter, (New Objective, Woburn,
MA) with a linear gradient from 2% to 50% solvent B
(acetonitrile, 0.1% formic acid) in 30 min at 200 nL/min
(obtained by flow-splitting). Mass spectra were acquired
using a data-dependent acquisition mode using Xcalibur
software version 2.0. Each full scan mass spectrum (400–
2,000m/z) was followed by collision-induced dissociation
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of the seven most intense ions. The dynamic exclusion
(30 s exclusion duration) function was enabled, and the
relative collisional fragmentation energy was set to 35%.
Database Searching
All MS/MS samples were analyzed using Mascot (Matrix
Science, London, UK; version 2.2.0, http://www.matrix
science.com; Perkins et al. 1999). Mascot was set up to
search the Uniref100 database (Schneider et al. 2005)
(release 13.2) assuming the digestion enzyme trypsin.
Mascot was searched with a fragment ion mass tolerance
of 0.50 Da and a parent ion tolerance of 2.0 Da.
Iodoacetamide derivative of cysteine was specified as a
fixed modification, and oxidation of methionine was
specified as a variable modification. Two missed cleavage
reactions were allowed.
Criteria for Protein Identification
Scaffold (version Scaffold-2_00_06, Proteome Software
Inc., Portland, OR) was used to validate MS/MS based
peptide and protein identifications. Peptide identifications
were accepted if they could be established at greater than
95.0% probability as specified by the Peptide Prophet
algorithm (Keller et al. 2002). Protein identifications were
accepted if they could be established at greater than 95.0%
probability and contained at least two identified peptides.
Protein probabilities were assigned by the Protein Prophet
algorithm (Nesvizhskii et al. 2003). Proteins that contained
similar peptides and could not be differentiated based on
MS/MS analysis alone were grouped to satisfy the
principles of parsimony.
Mass Spectrometry (Q-TOF 2)
Quadrupole time-of-flight (Q-TOF) 2 MS was performed at
the NRC Proteomics Facility, Institute for Biological
Sciences as follows.
Protein In-Gel Digestion
Bands of interest were washed with 30% acetonitrile/100 mM
ammonium bicarbonate then covered with an 8µg/ml solution
of modified porcine trypsin (sequencing grade, Promega,
Madison, WI) at 37°C overnight. Digestion products were
directly analyzed by MS without extraction.
Mass Spectrometry
Peptide mixtures were placed in a 96-well plate and
separated by LC (CapLC; Waters, Mississauga, ON)
equipped with a Dionex Acclaim PepMap100 C18, 5µm,
100 A, 300µm×5 mm trap and a C18, 75µm×5 cm
PicoFrit column (New Objectives) at a flow rate of
approximately 500 nl/min. The gradient used was 5–45%
acetonitrile/0.1% formic acid in 35 min followed by 45–
85% acetonitrile/0.1% formic acid in 3.5 min (column
wash). The ions were then analyzed with a Q-TOF 2 hybrid
mass spectrometer (Waters-Micromass, Mississauga, ON)
at one scan/second. The mass spectrometer was set to
operate in automatic MS/MS acquisition mode, and spectra
were acquired on doubly, triply, and quadruply charged ions
with the Masslynx software (Waters-Micromass, Missis-
sauga, ON). The scan range in TOF-MS mode was m/z
400-1600 (m/z 50-1600 in MS/MS mode), and MS/MS was
performed on the three most abundant multiple-charged
peaks for each TOF-MS scan.
Results
Patient Characteristics
Twenty-three adult patients with clinical manifestations of
soy allergy and nine adult patients exhibiting soy sensitivity
(as expressed by their ImmunoCAP score) were obtained
from two sources for this study. Case histories of these
individuals are summarized in Table 1. The cohort
consisted of 16 men and 16 women with a mean age of
34.2 years (18–64). This North American population
represents a wide spectrum of diagnosed soybean food
allergies and sensitivities. For allergic patients, Immuno-
CAP scores provide an estimate of the severity of reactions
against soybean, and these can be as high as >100 kU/L
(CS2), whereas for sensitive patients, the highest value in
this population was 10–14 kU/L (RM). As shown in
Table 1, allergic symptoms and sensitivities to soybean
and other legumes varied greatly and were generally not
well correlated with ImmunoCAP scores. Patients with a
very high ImmunoCAP score were not necessarily anaphy-
lactic; however, most patients with anaphylactic symptoms
to soy and peanuts tended to have a very high ImmunoCAP
score.
1D screening with Patient Sera
Thirty-two soy-allergic/sensitive patient sera were individu-
ally used in Western blot analysis to screen the tofu cultivar
Harovinton soybean proteins separated by 1D gel electro-
phoresis on 12.5% polyacrylamide gels (Figs. 1a, b). The
serum dilution of each patient was adjusted (titers varying
from 1/25 to 1/1,400) to allow visualization of only the most
reactive bands. In some cases, even a very low serum
dilution (high serum titer) did not reveal any intense bands
(HS 1/25, 08 1/50, TO 1/200). This result correlated with a
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low ImmunoCAP score (HS=0.6, 08=ND, TO=4.0 kU/L,
Table 1). In other cases, a high serum dilution revealed up to
ten bands, some of which were very intense (CS2 1/1400,
DB 1/800 and DP 1/800). The latter two patients are also
anaphylactic to soy. These three subjects share a common
IgE reaction against both the α subunit of β-conglycinin
(#3) and the A2 subunit of glycinin (#10) (see Table 3).
Holzhauser et al. (2009) have recently shown that these two
allergens, Gly m 5 (β-conglycinin) and Gly m 6 (glycinin),
were potentially indicative for severe allergic reactions to
soy in a European adult cohort. Most of the individual’s
serum in our study recognized between four and six
soybean proteins at varying intensities. However, some
sera had an intense reaction to only one specific protein
(LN, PK and RC). Generally, the ImmunoCAP score was
not well correlated to any one particular soybean protein, to
the number of bands, or to the intensity of the reaction.
In addition to the 32 clinically diagnosed patient sera
screened in this study, we used the non-allergic, non-
sensitive sera of four individuals who do not have any
known food allergies or sensitivities. A very faint back-
ground reaction was observed among each of these controls
against both the glycinin A3 subunit (#9) and the SBg7S
low kilodalton subunit (#15). The Western blots in this
study were detected with anti-human IgE as described in
“Materials and Methods,” and no bands were observed
when either anti-human IgG, IgA, or IgM were used as a
secondary antibody (data not shown), suggesting that
reactions to soybean proteins is exclusively IgE-mediated.
Four of the Canadian patient sera in this study (LM, CC,
RC, and CS) were previously used in a Western blot
analysis against soybean protein (Herian et al. 1990, 1992).
Bands labeled with red numbers on Figs. 1a and b were
excised from large 1D and/or 2D gels and subsequently
identified by tandem MS (see Table 2, red). By doing so,
we determined that the low Mw protein (20 KDa) band,
which Herian et al. (1990, 1992) detected, is in fact a late
embryonic abundant (LEA) group III protein (#16).
Fig. 1 Western blots of Harovinton soy proteins (15µg) separated on
12.5% polyacrylamide gels and probed with either American (a) or
Canadian (b) soy-allergic or sensitive patient sera and detected with
anti-human IgE-HRP (1/2,000). Molecular weight ranges are marked
on the left side, patient codes (see Table 1) are marked at the top, and
serum dilutions used are noted on the bottom in each panel. a
Coomassie-stained soy protein gel is illustrated on the extreme right.
Red numbered bands were picked and sent for tandem MS analysis
and identification (see Table 2, red). Red numbers also correspond to
the allergens described in Table 3
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Table 2 Identification of allergens by tandem MS
Sample Protein candidate Mass (kDa) / pI Mascot No. of Sequence coverage
(Swissprot) (theoritical) Score peptides
Fig. 3A* seed maturation protein PM31 17.7/6.1 379 8 MDWIGAYRGGQRSRDWCDPSSPFTDLWDPRRVGDADDITSSLAHAH
(2D) class I low mw heat shock protein (HSP) VDWRETDKAHIFRADLPGVKKEDLKVQVEENKILQISGERVKEKEDQN
(Q9XET1) DKWHRVERQCGSFLRRFRLPEDANPNQISCTLENGVLNVTVPKVEKK
PENKNVRQIDVV (57%)
Fig. 3C* seed maturation protein PM30 15.1/8.9 314 7 MASHRQSYEAGQTKGRTEEKTNQTMGNIGEKAQAAKEKTQEMAQAAK
(2D) late embryonic abundant (LEA) group III EKTQQTAQAAKDKTCDTSQAAKEKTQQNTGAAQQKTSEMGQSTKESA
(Q9XET0) QSGKDNTQGFLQQTGEKVKGAAQGATEAVKQTLGLGEHDQDNRRNY
(40%)
Fig. 3E Glycinin A3B4 subunit G5 (A3) 36.4/4.9 863 13 ITSSKFNECQLNNLNALEPDHRVESEGGLIETWNSQHPELQCAGVTVS





DEDEEEDQPRPDHPPQRPSRPEQQEPRGRGCQTRN (43%)  
Fig. 3E Beta subunit of beta conglycinin 48.0/5.7 1006 26 LKVREDENNPFYFRSSNSFQTLFENQNGRIRLLQRFNKRSPQLENLRD








5 Sucrose binding protein homolog S-64 55.8/6.3 2071 39 MATRAKLSLAIFLFFLLALISNLALGKLKETEVEEDPELVTCKHQCQQQR










8 Basic 7S globulin (SBg7S) [precursor] 43.7/8.8 965 17 VTPTKPINLVVLPVQNDGSTGLHWANLQKRTPLMQVPVLVDLNGNHL








10 Glycinin G2 precursor (A2) 31.6/4.9 1804 23 LREQAQQNECQIQKLNALKPDNRIESEGGFIETWNPNNKPFQCAGVA











14 Allergen Gly m Bd 28K [Fragment] 52.6/5.7 1132 16 KTTLLLLLFVLCHGVATTTMAFHDDEGGDKKSPKSLFLMSNSTRVFKTD









15 Basic 7S globulin (SBg7S) [Precursor] 16.3/7.7 345 5 STIVGSTSGGTMISTSTPHMVLQQSVYQAFTQVFAQQLPKQAQVKSVA
(1D)  low kDa subunit (P13917) PFGLCFNSNKINAYPSVDLVMDKPNGPVWRISGEDLMVQAQPGVTCLG
VMNGGMQPRAEITLGARQLEENLVVFDLARSRVGFSTSSLHSHGVKC
ADLFNFANA (38%)
* QTOF analysis; 1D, one dimensional gel electrophoresis; 2D, two dimensional gel electrophoresis
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Identification of Soy Allergens with Knockout Lines
Soy proteins extracted from Harovinton and various storage
protein knockout lines were also separated on a 12.5% 1D gel
and probed with patient serum to identify allergens. Figure 2
illustrates an example of this method of analysis in which
serum from one patient reacted to the glycinin subunit A3 on
a Western blot. On this blot, the glycinin A3 subunit was
missing from the soybean lines represented in lanes 1, 2, 3,
6, 7, and 9. It was present in the soybean lines in lanes 4, 5,
8, and 10, which showed conclusive bands at the correct
molecular mass of A3. By using protein extracts from seeds
lacking various combinations of glycinin subunits (A2, A3,
A4, and A5), it has been demonstrated that LM patient
serum reacted to only one member of this closely related
family of proteins. This highlights that the use of knockout
lines for allergen screening is a very powerful tool. Although
many knockout lines of the major storage proteins glycinin
and β-conglycinin have been created, at the present time,
there are limited knockout or null lines available for other
soybean proteins (examples include Kunitz trypsin inhibitor
(KTI), lipoxygenase, lectin, and P34).
2D Screening of Soybean Allergens with Patient Sera
Figure 3 illustrates four examples of 2D gel screening with
patient sera followed by tandem MS to identify allergens
(Table 2). This analysis allowed the identification of two
previously unreported soybean allergens, a class I low Mw
heat shock protein (HSP) and LEA group III protein in
Fig. 3b and d, respectively. It also demonstrated that the
identification of three known allergens, glycinin A3 and
both the α and β subunits of β-conglycinin, could be
confirmed in Fig. 3f and g, respectively.
Although the novel LEA allergen was detected on both
1D (Figs. 1a, b) and 2D (Fig. 3d) gels by patient serum
screening, HSP was only detected on a 2D gel (Fig. 3b) by
one patient serum (nine patients screened). Because of its
low relative abundance, as shown on a Coomassie-stained
2D gel (Fig. 3a), HSP may be masked by other more
abundant proteins at that location (~16 kDa) on a 1D gel,
which could explain why it has never been detected on a
1D blot with patient serum.
Soy Protein Identification by Tandem MS
All MS data obtained in Table 2 originated from large 1D
or 2D gels, which allowed for better resolution of separated
proteins. As expected, the Mascot score increased with the
size of the protein identified as more peptides could be
identified.
There was a good match between the predicted (Table 2)
and the observed (Fig. 3) Mw and pI of these proteins,
which suggests that the correct protein was identified by
MS.
Frequency of Patient Reactions Against Soy Proteins
The entire cohort of North Americans was used to calculate
the frequency of reactions to individual soybean proteins
(Table 3). The results are represented as the frequency
among the 32 patients, which demonstrate positive reac-
tions to specific or unidentified proteins in soybean seed as
shown on Fig. 1a and b. The most prevalent proteins
detected by IgE were glycinin subunit A3, followed by an
unidentified 30 kDa protein, Gly mBd 28K, SBg7S low
kilodalton subunit, unidentified 140 kDa protein, SBg7S,
P34/lectin, glycinin subunit A2, LEA group III protein, and
Fig. 2 a Coomassie-stained PVDF membrane after transfer of various
glycinin and β-conglycinin soybean knockout lines separated by
12.5% polyacrylamide gel. b Western blot of membrane in a probed
with LM serum (1/400) and detected with anti-human IgE-HRP
(1/2,000). Lane 1 Precision Plus markers, lanes 2–10 15µg of soy
protein extract. 2 α′A3 null, 3 α′A3 null, 4 α′A4A5 null, 5 α′A2
null, 6 A1A2A3A4A5 null, 7 α′A1A2A3 null, 8 A1A2A4A5 null, 9
α′A1A2A3A4A5 null, 10 Harovinton
370 Food Anal. Methods (2010) 3:363–374
the sucrose-binding protein homologue S-64. It is not
surprising to see an elevated frequency for A3 and SBg7S
low kilodalton subunit, as these allergens were also weakly
detected in non-soy-allergic patients. Both unidentified
proteins and S-64 reacted frequently, yet rather faintly.
Therefore, Gly mBd 28K, P34/lectin, glycinin A2, and
LEA were the allergens that reacted with the highest
frequency and intensity in our study. P34 and lectin were
grouped together because it was not possible to distinguish
between the two allergens on 1D gels. Only lectin was
detected by tandem MS analysis (Table 2), probably due to
its higher abundance compared to P34.
These findings seem to cast doubt on the previous
reports that the soybean P34/Gly mBd 30K allergen is the
most immunodominant allergen in the population (Ogawa
et al. 1991; Joseph et al. 2006) since several other proteins
are as significant, if not more significant, in this cohort.
Some early reports of soy allergen identification by Western
blot have used sera from children (Ogawa et al. 1991);
however, our study has demonstrated that, although this
protein was frequently detected by adult IgE, it was not
responsible for intense reactions (see band 11 on Fig. 1).
Discussion
We have demonstrated that high-resolution 1D and 2D gels
to separate soybean seed proteins prior to immunodetection
with human serum IgE, the use of soybean knockout lines,
and tandem MS analysis used in conjunction are powerful
methods for allergen identification. By comparing non-
allergic/sensitive sera with a 32 soy-allergic/sensitive
patient cohort, significant soybean allergens were detected
(Fig. 1). We demonstrated that some soybean proteins were
highly recognized by serum IgE (in more than 50% of
patients; see Fig. 1 and Table 3), and these included the G5
glycinin A3 subunit, a 30-kDa unidentified protein, Gly
mBd 28K, Basic 7S globulin precursor (SBg7S) and its low
Mw subunit, a 140-KDa unidentified protein, P34/lectin, G2
glycinin A2 subunit, a 15-kDa LEA group III protein, and
sucrose-binding protein homologue S-64.
As previously mentioned, the A3 and SBg7S may have
been more frequently detected in soy-allergic and sensitive
sera partly because of their weak background reaction with
non-allergic non-sensitive sera. Therefore, the reported
frequency in Table 3 may be overestimated; however, in a
few soy-allergic patients, the A3 band was significantly
more intense than background (Fig. 1) and should still be
considered a significant allergen. In the case of SBg7S, it
was detected by MS, once as the full-length protein of
44 kDa (band 8, Fig. 1) and once as the low kilodalton
subunit (band 15, Fig. 1). The fact that it was recognized in
two independent experiments raises the confidence level
that it is, in fact, a true novel allergen. Moreover, both
SBg7S forms (16 and 44 kDa) were often simultaneously
recognized by the same patient IgE (see CO, CY, RJ, RM,
DB, AG, and LM in Fig. 1).
The early study by Ogawa et al. (1991) was instrumental
in ranking the frequency of IgE-binding soybean proteins
among a group of Japanese children (mean age 6 years)
with atopic dermatitis. Although they reported a high
frequency of reactions to the protein Gly m Bd 30 K (later
described as P34), in this present study of adults (mean age,
34 years), with known soybean allergies/sensitivities, the
frequency and intensity of reaction of P34 was not superior
to some other proteins (Fig. 1, Table 3). Because it was not
possible to distinguish between lectin and P34 in Fig. 1, as
they co-migrated on the gel, the frequency of reaction
reported in Table 3 is the sum of serum IgE binding to both.
A similar failure to detect P34 by MS has recently been
reported (Batista et al. 2007). Therefore, it is possible that,
individually, these allergens react to less than 50% of the
population. In fact, preliminary results of patient serum
screening on 2D gels would seem to indicate that these two
allergens are not major or are not being detected by 2D gel
screening (data not shown). We are presently making use of
a recently discovered P34-null germplasm to further
investigate these North American patients (Joseph et al.
2006). Although this group of patients is relatively small in
number, it suggests a trend with regard to the soybean
proteins most likely to provoke allergic reactions among
North Americans. The list of allergenic proteins and their
frequencies in this cohort is presented to demonstrate the
results of the largest screening of soy allergic patients to
date, but it is not intended to be a complete nor absolute
list. It is very difficult to predict with any degree of
certainty whether these trends would translate to the overall
soy allergic population.
While several studies have shown that IgE from soy-
sensitive patients react primarily to the glycinin and β-
conglycinin fractions (Holzhauser et al. 2009; Ogawa et al.
1995), we have shown in this study that a high percentage
of patient IgE also reacts to non-storage proteins, including
a seed maturation protein known as LEA protein. In fact,
two patients in this cohort had an IgE reaction only to LEA
protein (Figs. 1a (PK), b(RC). LEA proteins are known to
play a role in desiccation and stress tolerance in many plant
seeds, allowing them to survive the dry storage phase. This
particular type of LEA protein (group III) and the gene
encoding it have been well characterized by Shih et al.
(2004). We are continuing the characterization of this
allergen by epitope mapping in an effort to better define
regions of allergenicity.
Several studies have reported that the Gly m Bd 28K is
an allergen (Hiemori et al. 2004). It has been determined
that both the 23 kDa C-terminal domain and the 28 kDa N-
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terminal domain of this protein were detected by serum
IgE. Our results, as shown in Fig. 1, band 14, indicate
that Gly m Bd 28K is a protein of ~24 kDa, which is
consistent with this previous report. MS analysis of this
spot (Table 2) also indicated that both domains bind to
serum IgE. A similar number of peptides were detected by
MS for both the N-terminal (seven) and the C-terminal
(nine) domains (Table 2). Upon careful observation of
Fig. 1a, there appears to be a doublet in the ~24 kDa
vicinity, which could contain both domains of Gly m Bd
28K.
Another seed maturation protein, which was identified
by 2D gel Western blot analysis in this study, was the PM31
HSP (Fig. 3b). This protein was only detected by the IgE of
one patient in a 2D Western blot; therefore, it is somewhat
premature to speculate on its relative significance, but at
this point, it does not appear to be a major allergen.
However, other HSP proteins have been demonstrated to
bind to human IgE from patients sensitized to penicillium
(Shen et al. 1997), cystic echinococcosis (Ortona et al.
2003), and to corn and wheat dust (Chiung et al. 2000).
Kunitz trypsin inhibitor (KTI) has been previously
identified as a soy allergen (Moroz and Yang 1980).
Despite the fact that it is a well-resolved protein on a pH
4-7 2D gel (pI ~4.7, Mw ~18 KDa), KTI was never detected
by these 32 patient sera in IgE Western blot analysis. KTI
null genotypes are available to further screen against this
North American cohort; however, it appears that it is a
minor allergen at best. Likewise, the basic subunit of
glycinin G2 (B2) has also been previously reported as an
allergen (Helm et al. 2000); however, in this study, it was
not possible to detect it by patient sera on either 1D or 2D
IgE Western blots.
We demonstrated in this study that A2 and A3 glycinin
subunits are some of the most reactive to patient IgE in
Western blots (Figs. 1a, b, 2, and 3). These findings are
curious given the high amino acid sequence homology
(78%) between the A3 and A4 subunits. One would have
Table 3 Frequency of patient reactions on 1D gels and candidate soy allergen
Sample Frequency Protein allergen MW (kDa) Swissprot
(%)
1 10 - >140
2 63 - 140
3 33 -conglycinin (  ) 70
4 13 - 68
5 53 Sucrose binding protein homolog S-64 56 Q9SP11 
6 20 - 55
7 27 -conglycinin ( ) 48 O22121 
8 60 Basic 7S globulin precursor (Bg) (SBg7S) 44 P13917 
9 93 Glycinin (G5) A3B4 subunit (A3) 36 Q7GC77 
10 57 Glycinin G2 precursor (A2) 32 P04405 
11 60 P34/lectin 31 P22895/P05046 
12 77 - 30
13 27 - 26
14 73 Gly m Bd 28K 24 Q9AVK8 
15 70 SBg7S low kDa subunit 18 P13917
16 57 LEA 15 Q9XET0
17 27 - 13
18 10 - 12
-, not determined, red numbers represent samples taken from 1D gels and analyzed by MS; green numbers
represent samples taken from both 1D and 2D gels and analyzed by MS; bold text represent novel allergens
not yet reported in the literature.
Fig. 3 Coomassie-stained 2D gels of Harovinton soybean proteins
(75µg) and IgE Western blots. a 15%, 5–8 2D gel; b membrane
transfer from a probed with DP serum (1/800); c 15%, 6–11 2D gel; d
membrane transfer from c probed with RC serum (1/100); e 12.5%, 4–
7 2D gel; f membrane transfer from e probed with LM serum (1/300);
g membrane transfer from e probed with CS serum (1/100). Anti-
human IgE-HRP was used at 1/2,000 in all blots except for d where it
was used at 1/2,500. Molecular weight and pH ranges are indicated on
the left and at the top of each gel/blot, respectively. Identified allergens
are indicated with an arrow

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expected to also see the A4 subunit detected with patient
serum; yet, the A4 subunit, which is well-resolved and
identified on a pH 4–7 2D gel (Zarkadas et al. 2007), was
never detected in IgE Western blots. We have not yet
screened gels with appropriate pH and Mw ranges to study
the reactivity of the A5 subunit, which shares even higher
amino acid homology (85%) with A3.
Another example of the exquisite specificity and
sensitivity of patient serum IgE toward soybean proteins
was the α subunit of β-conglycinin, which was recognized
by serum IgE of patient CS, whereas the highly homolo-
gous (82%) α′ subunit was not (Fig. 3). Epitope mapping
and alanine scanning experiments may allow us to elucidate
the antigenic regions, linear or conformational epitopes of
these and other allergens, which are responsible for this
high degree of specificity. Ogawa et al. have previously
observed this same phenomena with serum IgE reactions
toward the α subunit of β-conglycinin (Ogawa et al. 1995).
A limitation of doing these patient surveys on small format
1D gels is the ability to conclusively resolve allergenic
proteins, whereas the resolution would be considerably better
on large format gels and would allow for better alignment of
individual blots and better protein identification. Although this
is a preliminary screen of this cohort group, we are confident
that the large format gels used to isolate proteins for MS have
correctly identified the proteins listed in Tables 2 and 3.
Another of the limitations of 1D gel electrophoresis for
MS analysis is the fact that the most abundant proteins in
the band are most often identified; however, the most
abundant protein in the mixture is not necessarily the most
allergenic. Using large format 2D gels of high resolution
(those whose pH ranges provide the best separation for the
protein under investigation) may help alleviate this problem
and reduce the chances of cross-contamination but may also
reduce the amount of protein per spot and, therefore, is
likely to return a lower Mascot score, as was observed
herein.
By using soybean protein knockout lines where possible,
high-resolution 2D gel Western blots with well-characterized
allergic patient serum, coupled with MS analysis and
continually increasing genome sequences in public data-
bases, the confidence level of allergen identification should
rise. The simultaneous use of these three methods could
become indispensable to conclusively identify new allergens
with the utmost degree of confidence.
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